Short description
A product focused pharmaceutical company.
Description
Theraly is a product focused pharmaceutical company with a goal to efficiently generate medically important, stable, and long-acting therapies. Theraly enables products using its proprietary platform technology that can empower short-acting peptides and proteins by dramatically increasing their half-lives while maintaining potency. Their lead program is a preclinical stage product in development for organ fibrosis. TLY012, has shown therapeutic efficacy in a number of pre-clinical models of organ fibrosis, autoimmune/inflammatory conditions, and in oncology.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Baltimore, Maryland, United States, North America
Founded on
January 1, 2013
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Investors
Absolutely Noaccess
Sign in for full access
Founders
Justin Hanes, Kang Choon Lee, Mark Rampy, Martin G. Pomper, Seulki Lee